- Home
- NBTX vs OMDA Comparison
NBTX vs OMDA Comparison
Compare NBTX & OMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- OMDA
- Stock Information
- Founded
- NBTX 2003
- OMDA 2011
- Country
- NBTX France
- OMDA United States
- Employees
- NBTX N/A
- OMDA N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- OMDA Medical/Nursing Services
- Sector
- NBTX Health Care
- OMDA Health Care
- Exchange
- NBTX Nasdaq
- OMDA Nasdaq
- Market Cap
- NBTX 1.3B
- OMDA 1.3B
- IPO Year
- NBTX 2020
- OMDA 2025
- Fundamental
- Price
- NBTX $21.69
- OMDA $19.00
- Analyst Decision
- NBTX Strong Buy
- OMDA Strong Buy
- Analyst Count
- NBTX 1
- OMDA 9
- Target Price
- NBTX $8.00
- OMDA $26.44
- AVG Volume (30 Days)
- NBTX 99.0K
- OMDA 580.7K
- Earning Date
- NBTX 09-30-2025
- OMDA 11-06-2025
- Dividend Yield
- NBTX N/A
- OMDA N/A
- EPS Growth
- NBTX N/A
- OMDA N/A
- EPS
- NBTX N/A
- OMDA N/A
- Revenue
- NBTX $11,930,711.00
- OMDA $232,342,000.00
- Revenue This Year
- NBTX N/A
- OMDA $43.42
- Revenue Next Year
- NBTX $122.94
- OMDA $20.01
- P/E Ratio
- NBTX N/A
- OMDA N/A
- Revenue Growth
- NBTX N/A
- OMDA 89.23
- 52 Week Low
- NBTX $2.76
- OMDA $14.14
- 52 Week High
- NBTX $30.35
- OMDA $28.40
- Technical
- Relative Strength Index (RSI)
- NBTX 53.91
- OMDA N/A
- Support Level
- NBTX $19.90
- OMDA N/A
- Resistance Level
- NBTX $23.56
- OMDA N/A
- Average True Range (ATR)
- NBTX 1.39
- OMDA 0.00
- MACD
- NBTX 0.06
- OMDA 0.00
- Stochastic Oscillator
- NBTX 69.36
- OMDA 0.00
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About OMDA Omada Health Inc. Common Stock
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The Company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.